Dosing will be a key success factor in repurposing antivirals for COVID-19

Patrick F. Smith; Michael Dodds; Darren Bentley; Karen Yeo; Craig Rayner

doi:10.1111/bcp.14314

Dosing will be a key success factor in repurposing antivirals for COVID-19

Patrick F. Smith
, Michael Dodds
, Darren Bentley
, Karen Yeo
, Craig Rayner

Pharmacy

Certara

Research output: Contribution to journal › Comment/debate

30 Scopus citations

Original language	English
Pages (from-to)	3451-3454
Number of pages	4
Journal	British Journal of Clinical Pharmacology
Volume	87
Issue number	9
DOIs	https://doi.org/10.1111/bcp.14314
State	Published - Sep 2021

Access to Document

10.1111/bcp.14314

Cite this

@article{2bf99ed3a9244a8782c09681183c19a5,

title = "Dosing will be a key success factor in repurposing antivirals for COVID-19",

author = "Smith, \{Patrick F.\} and Michael Dodds and Darren Bentley and Karen Yeo and Craig Rayner",

year = "2021",

month = sep,

doi = "10.1111/bcp.14314",

language = "English",

volume = "87",

pages = "3451--3454",

journal = "British Journal of Clinical Pharmacology",

issn = "0306-5251",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "9",

}

TY - JOUR

T1 - Dosing will be a key success factor in repurposing antivirals for COVID-19

AU - Smith, Patrick F.

AU - Dodds, Michael

AU - Bentley, Darren

AU - Yeo, Karen

AU - Rayner, Craig

PY - 2021/9

Y1 - 2021/9

UR - https://www.scopus.com/pages/publications/85083557701

U2 - 10.1111/bcp.14314

DO - 10.1111/bcp.14314

M3 - Comment/debate

C2 - 32304110

AN - SCOPUS:85083557701

SN - 0306-5251

VL - 87

SP - 3451

EP - 3454

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

IS - 9

ER -

Dosing will be a key success factor in repurposing antivirals for COVID-19

Access to Document

Other files and links

Fingerprint

Cite this